BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 27540032)

  • 1. MicroRNA Theranostics in Prostate Cancer Precision Medicine.
    Matin F; Jeet V; Clements JA; Yousef GM; Batra J
    Clin Chem; 2016 Oct; 62(10):1318-33. PubMed ID: 27540032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNAs Role in Prostate Cancer.
    Balacescu O; Dumitrescu RG; Marian C
    Methods Mol Biol; 2018; 1856():103-117. PubMed ID: 30178248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs as Biomarkers for Diagnosis, Prognosis and Theranostics in Prostate Cancer.
    Bertoli G; Cava C; Castiglioni I
    Int J Mol Sci; 2016 Mar; 17(3):421. PubMed ID: 27011184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miRNAs in prostate cancer: Intercellular and extracellular communications.
    Urabe F; Yamamoto Y; Kimura T
    Int J Urol; 2022 Dec; 29(12):1429-1438. PubMed ID: 36122303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic, prognostic and predictive value of cell-free miRNAs in prostate cancer: a systematic review.
    Endzeliņš E; Melne V; Kalniņa Z; Lietuvietis V; Riekstiņa U; Llorente A; Linē A
    Mol Cancer; 2016 May; 15(1):41. PubMed ID: 27189160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosomal microRNAs in liquid biopsies: future biomarkers for prostate cancer.
    Valentino A; Reclusa P; Sirera R; Giallombardo M; Camps C; Pauwels P; Crispi S; Rolfo C
    Clin Transl Oncol; 2017 Jun; 19(6):651-657. PubMed ID: 28054319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNAs in prostate cancer: from biomarkers to molecularly-based therapeutics.
    Gordanpour A; Nam RK; Sugar L; Seth A
    Prostate Cancer Prostatic Dis; 2012 Dec; 15(4):314-9. PubMed ID: 22333688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNAs as Diagnostic, Prognostic, and Therapeutic Biomarkers in Prostate Cancer.
    Aghdam AM; Amiri A; Salarinia R; Masoudifar A; Ghasemi F; Mirzaei H
    Crit Rev Eukaryot Gene Expr; 2019; 29(2):127-139. PubMed ID: 31679268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating microRNAs: macro-utility as markers of prostate cancer?
    Selth LA; Tilley WD; Butler LM
    Endocr Relat Cancer; 2012 Aug; 19(4):R99-R113. PubMed ID: 22492480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Updates and current challenges in microRNA research for personalized medicine in ovarian cancer.
    Mandilaras V; Vernon M; Meryet-Figuière M; Karakasis K; Lambert B; Poulain L; Oza A; Denoyelle C; Lheureux S
    Expert Opin Biol Ther; 2017 Aug; 17(8):927-943. PubMed ID: 28641048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNAs in prostate cancer: From function to biomarker discovery.
    Moustafa AA; Kim H; Albeltagy RS; El-Habit OH; Abdel-Mageed AB
    Exp Biol Med (Maywood); 2018 Jun; 243(10):817-825. PubMed ID: 29932371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging role of microRNAs in prostate cancer: implications for personalized medicine.
    Gandellini P; Folini M; Zaffaroni N
    Discov Med; 2010 Mar; 9(46):212-8. PubMed ID: 20350487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Potential of MicroRNAs as Prostate Cancer Biomarkers.
    Fabris L; Ceder Y; Chinnaiyan AM; Jenster GW; Sorensen KD; Tomlins S; Visakorpi T; Calin GA
    Eur Urol; 2016 Aug; 70(2):312-22. PubMed ID: 26806656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent scenario of microRNA as diagnostic and prognostic biomarkers of prostate cancer.
    Shukla KK; Misra S; Pareek P; Mishra V; Singhal B; Sharma P
    Urol Oncol; 2017 Mar; 35(3):92-101. PubMed ID: 27890424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of expression profiling of circulating microRNAs in men with prostate cancer.
    Kelly BD; Miller N; Healy NA; Walsh K; Kerin MJ
    BJU Int; 2013 Jan; 111(1):17-21. PubMed ID: 22612403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of microRNA signature and potential pathway targets in prostate cancer.
    Moustafa AA; Ziada M; Elshaikh A; Datta A; Kim H; Moroz K; Srivastav S; Thomas R; Silberstein JL; Moparty K; Salem FE; El-Habit OH; Abdel-Mageed AB
    Exp Biol Med (Maywood); 2017 Mar; 242(5):536-546. PubMed ID: 27903835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA profiles of prostate carcinoma detected by multiplatform microRNA screening.
    Wach S; Nolte E; Szczyrba J; Stöhr R; Hartmann A; Ørntoft T; Dyrskjøt L; Eltze E; Wieland W; Keck B; Ekici AB; Grässer F; Wullich B
    Int J Cancer; 2012 Feb; 130(3):611-21. PubMed ID: 21400514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of cell-free microRNAs in the urine of patients with prostate cancer.
    Korzeniewski N; Tosev G; Pahernik S; Hadaschik B; Hohenfellner M; Duensing S
    Urol Oncol; 2015 Jan; 33(1):16.e17-16.e22. PubMed ID: 25445383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA expression and function in prostate cancer: a review of current knowledge and opportunities for discovery.
    Kumar B; Lupold SE
    Asian J Androl; 2016; 18(4):559-67. PubMed ID: 27056344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating miRNAs: roles in cancer diagnosis, prognosis and therapy.
    Cheng G
    Adv Drug Deliv Rev; 2015 Jan; 81():75-93. PubMed ID: 25220354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.